Compare CRGO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRGO | RZLT |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 187.3M |
| IPO Year | N/A | N/A |
| Metric | CRGO | RZLT |
|---|---|---|
| Price | $2.73 | $2.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 120.7K | ★ 6.6M |
| Earning Date | 02-23-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,642,000.00 | N/A |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.55 | N/A |
| 52 Week Low | $1.72 | $1.07 |
| 52 Week High | $4.42 | $11.46 |
| Indicator | CRGO | RZLT |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 40.37 |
| Support Level | $2.00 | $2.36 |
| Resistance Level | $2.44 | $2.92 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | 0.07 | 0.32 |
| Stochastic Oscillator | 88.89 | 84.91 |
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.